<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>63(3)</volume><submitter>Suzuki Y</submitter><pubmed_abstract>4β-Hydroxycholesterol (4β-OHC) is formed by Cytochrome P450 (CYP)3A and has drawn attention as an endogenous phenotyping probe for CYP3A activity. However, 4β-OHC is also increased by cholesterol autooxidation occurring in vitro due to dysregulated storage and in vivo by oxidative stress or inflammation, independent of CYP3A activity. 4α-hydroxycholesterol (4α-OHC), a stereoisomer of 4β-OHC, is also formed via autooxidation of cholesterol, not by CYP3A, and thus may have clinical potential in reflecting the state of cholesterol autooxidation. In this study, we establish a sensitive method for simultaneous quantification of 4β-OHC and 4α-OHC in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry. Plasma samples were prepared by saponification,</pubmed_abstract><journal>Journal of lipid research</journal><pagination>100184</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8953653</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping.</pubmed_title><pmcid>PMC8953653</pmcid><pubmed_authors>Toyama D</pubmed_authors><pubmed_authors>Shin T</pubmed_authors><pubmed_authors>Mimata H</pubmed_authors><pubmed_authors>Ono H</pubmed_authors><pubmed_authors>Ando T</pubmed_authors><pubmed_authors>Itoh H</pubmed_authors><pubmed_authors>Oda A</pubmed_authors><pubmed_authors>Tanaka R</pubmed_authors><pubmed_authors>Suzuki Y</pubmed_authors><pubmed_authors>Negami J</pubmed_authors><pubmed_authors>Ohno K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping.</name><description>4β-Hydroxycholesterol (4β-OHC) is formed by Cytochrome P450 (CYP)3A and has drawn attention as an endogenous phenotyping probe for CYP3A activity. However, 4β-OHC is also increased by cholesterol autooxidation occurring in vitro due to dysregulated storage and in vivo by oxidative stress or inflammation, independent of CYP3A activity. 4α-hydroxycholesterol (4α-OHC), a stereoisomer of 4β-OHC, is also formed via autooxidation of cholesterol, not by CYP3A, and thus may have clinical potential in reflecting the state of cholesterol autooxidation. In this study, we establish a sensitive method for simultaneous quantification of 4β-OHC and 4α-OHC in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry. Plasma samples were prepared by saponification,</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-22T07:46:43.845Z</modification><creation>2025-04-05T22:20:47.977Z</creation></dates><accession>S-EPMC8953653</accession><cross_references><pubmed>35181316</pubmed><doi>10.1016/j.jlr.2022.100184</doi></cross_references></HashMap>